Cefoperazone is a semisynthetic cephalosporin resistant to 3-lactamase inactivation. It possesses a broad spectrum of antibacterial activity against both gram-positive and gram-negative organisms and is highly active against the usual community-acquired pathogens of meningitis, Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae, including P-lactamase-producing strains (5, 7, 10) . The emergence of Haemophilus strains resistant to ampicillin or chloramphenicol or both (8, 14) and pneumococci resistant to penicillin (15) , in addition to the activity of cefoperazone against many gram-negative nosocomial agents of meningitis, warranted Collection of specimens for cefoperazone analysis. Cefoperazone doses were infused over a mean time period of 20 min (range, 8 to 50 min). Serum levels were obtained at a mean time of 13 min (range, 4 to 30 min) after the termination of intravenous infusion or, in group III, after completion of the third infusion. Subsequent serum levels were obtained immediately after completion of lumbar punctures or, in group III, at a mean time of 145 min (range, 94 to 261 min) after the end of the intravenous infusion. Lumbar punctures were performed at a mean time of 141 min (range, 90 to 254 min) after the end of the infusion.
Cefoperazone assay. Cefoperazone concentrations in CSF and serum were measured by microbiological assay with an Escherichia coli strain (USC 81-311) for which the minimal bactericidal concentrations of chloramphenicol and ampicillin were 100 and 200 ,ug/ml, respectively. Ampicillin and chloramphenicol concentrations of 1 to 200 ,ug/ml had no effect on zone sizes in the presence of cefoperazone. Assay organisms were seeded (0.40 ml of an overnight suspension of 109 organisms per ml diluted in 40 ml; final concentration, 107 organisms per ml) on plates of antibiotic medium no. 11 (Difco Laboratories) prepared with 50-,ul agar wells. All unknown samples were run in duplicate when sufficient amounts were available. Duplicate standard curves were constructed for each CSF (12.5, 3.14, 1.6, and 0.8 ,ug of cefoperazone per ml) and serum (50, 25, 6.25, and 3.13 Fxg of cefoperazone per ml) assay. For serum obtained within 1 h of drug administration, a 1:10 dilution was used; for samples obtained 2 to 5 h after drug administration, a 1:5 dilution was used. Results were read after 4 h of incubation at 37°C. The lower limit of assay detectability was 0.8 ,ug of cefoperazone per ml.
RESULTS
Peak drug concentrations in serum ranged from 62.5 to 440 ,ug of cefoperazone per ml (mean, 252 ,ug/ml). Those obtained at the time of lumbar puncture ranged from 40 to 247.5 (mean, 96.3 ,ug/ml). Mean serum concentrations at the time of lumbar puncture were 85, 90, and 100 ,u.g/ml for groups I, II, and III, respectively. (6, 9, 11, 12) , cefotaxime (1, 3), ceftizoxime (2) , and ceftriaxone (4). Unlike previous experience with cephalosporin antibiotics, these drugs have performed well in animal models and in pharmacokinetic and clinical studies. However, the relative merits of each must be clarified by further prospective clinical studies. Scheld and co-workers compared cefoperazone with penicillin and ampicillin in experimental meningitis in rabbits (13) . Cefoperazone achieved a mean penetration of 6.4% and concentrations in CSF of 9.4 ± 3.6 jig/ml (mean ± standard deviation). A significantly more rapid bactericidal effect of cefoperazone was observed after 4 h of treatment, as compared with penicillin and ampicillin, in meningitis caused by pneumococcal and Haemophilus strains, respectively. Further, cefoperazone was significantly more rapidly bactericidal than either ampicillin or chloramphenicol against ,-lactamase-producing H. influenzae. Recently, Chartrand and coworkers (S. Chartrand, I. Johnston 4.4 p,g/ml after single doses and concentrations of 10.5 ,ig/ml after multiple doses; CSF/serum ratios varied from 2.9 to 5.9%, depending on the dosage regimen and the day on which CSF was sampled. Feldman and co-workers found drug concentrations in CSF of as high as 13.3 ± 19 ,ug/ml (mean ± standard deviation) during day 5 of therapy, peaking at 1 h after the dose administration. All CSF samples had detectable cefoperazone concentrations, with a minimal assay detectability of 0.5 ,ug/ml by highpressure liquid chromatography.
The frequency of nondetectable levels in our studies was particularly disturbing. Differences in methodology may partly account for the apparent disparity between our results and those of others. Most investigators have measured drug concentrations after the administration of multiple doses of cefoperazone. Feldman et al. collected all CSF samples after -three doses. Chartrand and co-workers collected samples after only a single dose on day 2; levels might be expected to be higher at this time owing to meningeal inflammation. Measuring levels in CSF after the administration of a single dose may be important clinically, since assurance that ANTIMICROB. AGENTS CHEMOTHER. It is clear that results of studies of cephalosporin penetration into CSF must be interpreted with caution. Although ampicillin and penicillin are effective despite a seemingly variable penetration, first-and second-generation cephalosporins are not reliably effective. The hope for thirdgeneration cephalosporins is that their increased antimicrobial potency will overcome the disparities among measurable levels in CSF, antimicrobial activity, and clinical performance. Although the mean CSF levels of cefoperazone were above the 90o minimal inhibitory concentrations for most meningeal pathogens, the frequency of levels below the limit of assay detectability (0.8 ,ug/ml) was disturbing. Cefoperazone may penetrate less well than other cephalosporins currently being evaluated and therefore may be a suboptimal candidate antibiotic for the treatment of bacterial meningitis.
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